Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

June 02, 2015 6:43 AM ET

Personal Products

Company Overview of Natraceutical SA

Company Overview

Natraceutical SA develops and manufactures pharmaceutical products for customers in Europe. The company’s structure includes four divisions: Industrial Services Division; Pharma Division; R&D and Regulatory Division; and Biotech Division. The Industrial Services Division provides manufacturing services and out-licensing dossiers of specialized products, such as sterile products for injection, freeze-dried products, and penicillin/cephalosporin antibiotics, as well as topical formulations. The Pharma Division offers products in the fields of dermatology, women's care, respiratory, anti-infectious, pediatrics, and retail consumer healthcare products. The R&D and Regulatory Division engages in ...

Avenue Alcalde Barnils


Edif. A, 1º 3ª

Street Cugat del Vallés

Barcelona,  080174


Founded in 1929


34 93 584 81 85

Key Executives for Natraceutical SA

Natraceutical SA does not have any Key Executives recorded.

Natraceutical SA Key Developments

Reig Jofre Group Wins GBP 230 Million Multiple Awardees Contract for Supplying Generic Pharmaceuticals

Reig Jofre Group won a GBP 230 million multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for the supply of generic pharmaceuticals.

Reig Jofre Announces Earnings Results for the First Quarter of 2015

Reig Jofre announced earnings results for the first quarter of 2015. For the quarter, the company reported net profit of EUR 5.3 million (USD 6 million) in the first quarter, 41.1% more than in the same period of 2014. The company achieved sales of EUR 43 million, representing an increase of 5.3% compared to EUR 41 million in same period last year. The positive performance has been driven by development and manufacturing for third parties and the company's own research and development. At the end of March, net financial debt stood at EUR 17.7 million. The 5.3% sales increase fulfils company’s expectations after merging with Natraceutical. The company has stated that the first quarter has been one of ‘strong seasonality’ on pharmacy sales of nutritional supplements for weight control. Therefore, the first-quarter results cannot be extrapolated linearly to the rest of the year.

Natraceutical SA to Report Q1, 2015 Results on May 05, 2015

Natraceutical SA announced that they will report Q1, 2015 results on May 05, 2015

Recent Private Companies Transactions

April 8, 2015
Derma UK Ltd
June 27, 2014
Natraceutical SA, Prior to Reverse Merger with Laboratorio Reig Jofre, S.A
June 13, 2014
Oryzon Genomics S.A., Diagnostics Business

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Natraceutical SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at